Two Sigma Investments’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Two Sigma Investments’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-41,370	Closed	-$1.4M	–	4944
2021 Q2	$1.4M	Buy	+41,370	New	+$1.05M	﹤0.01%	2187
2020 Q4	–	Sell	-138,380	Closed	-$2.8M	–	3924
2020 Q3	$2.8M	Sell	138,380 -200	-0.1%	-$4.88K	0.01%	1109
2020 Q2	$4.16M	Buy	138,580 +121,543	+713%	+$4.38M	0.02%	726
2020 Q1	$535K	Sell	17,037 -41,798	-71%	-$1.45M	﹤0.01%	1877
2019 Q4	$2.77M	Buy	+58,835	New	+$1.7M	0.01%	1336

Two Sigma Investments's CNST Position: Q3 2021 in Review

Two Sigma Investments sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 41,370 shares — an estimated $1.4M sold.

Two Sigma Investments first reported a position in CNST in Q4 2019 and held it in 5 quarters. The position peaked at $4.16M in Q2 2020. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

Two Sigma Investments reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
Two Sigma Investments sold 41,370 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $1.4M.
Two Sigma Investments first reported a position in Constellation Pharmaceuticals, Inc. in Q4 2019 and held it in 5 quarters.
Two Sigma Investments's Constellation Pharmaceuticals, Inc. position peaked at $4.16M in Q2 2020.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Two Sigma Investments's 13F filing for Q3 2021, filed 15 Nov 2021.